PolarityTE Announces Clinical Data from Two Studies Showing 12-Week Closure of Difficult-to-Treat Lower Extremity Chronic Wounds Using SkinTE

SALT LAKE CITY, May 10, 2019 -- (Healthcare Sales & Marketing Network) -- PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing and commercializing regenerative tissue products and biomaterials, announced today data from two pilot studies on ... Regenerative Medicine, Wound Care PolarityTE, SkinTE, diabetic foot ulcers
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news